BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26099688)

  • 1. Usefulness of data from magnetic resonance imaging to improve prediction of dementia: population based cohort study.
    Stephan BC; Tzourio C; Auriacombe S; Amieva H; Dufouil C; Alpérovitch A; Kurth T
    BMJ; 2015 Jun; 350():h2863. PubMed ID: 26099688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain MRI markers and dropout in a longitudinal study of cognitive aging: the Three-City Dijon Study.
    Glymour MM; Chêne G; Tzourio C; Dufouil C
    Neurology; 2012 Sep; 79(13):1340-8. PubMed ID: 22972647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.
    Smith EE; Egorova S; Blacker D; Killiany RJ; Muzikansky A; Dickerson BC; Tanzi RE; Albert MS; Greenberg SM; Guttmann CR
    Arch Neurol; 2008 Jan; 65(1):94-100. PubMed ID: 18195145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline.
    den Heijer T; van der Lijn F; Koudstaal PJ; Hofman A; van der Lugt A; Krestin GP; Niessen WJ; Breteler MM
    Brain; 2010 Apr; 133(Pt 4):1163-72. PubMed ID: 20375138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a priori risk model for extensive white matter lesions in people age 65 years or older: the Dijon MRI study.
    Tully PJ; Qchiqach S; Pereira E; Debette S; Mazoyer B; Tzourio C
    BMJ Open; 2017 Dec; 7(12):e018328. PubMed ID: 29289936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people.
    den Heijer T; Geerlings MI; Hoebeek FE; Hofman A; Koudstaal PJ; Breteler MM
    Arch Gen Psychiatry; 2006 Jan; 63(1):57-62. PubMed ID: 16389197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological Decline Improves Prediction of Dementia Beyond Alzheimer's Disease Biomarker and Mild Cognitive Impairment Diagnoses.
    Nation DA; Ho JK; Dutt S; Han SD; Lai MHC;
    J Alzheimers Dis; 2019; 69(4):1171-1182. PubMed ID: 31104015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large Perivascular Spaces Visible on Magnetic Resonance Imaging, Cerebral Small Vessel Disease Progression, and Risk of Dementia: The Age, Gene/Environment Susceptibility-Reykjavik Study.
    Ding J; Sigurðsson S; Jónsson PV; Eiriksdottir G; Charidimou A; Lopez OL; van Buchem MA; Guðnason V; Launer LJ
    JAMA Neurol; 2017 Sep; 74(9):1105-1112. PubMed ID: 28715552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal magnetic resonance imaging vascular changes, apolipoprotein E genotype, and development of dementia in the neurocognitive outcomes of depression in the elderly study.
    Steffens DC; Potter GG; McQuoid DR; MacFall JR; Payne ME; Burke JR; Plassman BL; Welsh-Bohmer KA
    Am J Geriatr Psychiatry; 2007 Oct; 15(10):839-49. PubMed ID: 17623814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ROSAS Cohort: A Prospective, Longitudinal Study of Biomarkers for Alzheimer's Disease. Strategy, Methods and Initial Results.
    de Mauléon A; Soto M; Kiyasova V; Delrieu J; Guignot I; Galtier S; Lilamand M; Cantet C; Lala F; Sastre N; Andrieu S; Pueyo M; Ousset PJ; Vellas B
    J Prev Alzheimers Dis; 2017; 4(3):183-193. PubMed ID: 29182709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White Matter Lesions are Associated with Specific Depressive Symptom Trajectories among Incident Depression and Dementia Populations: Three-City Dijon MRI Study.
    Tully PJ; Debette S; Mazoyer B; Tzourio C
    Am J Geriatr Psychiatry; 2017 Dec; 25(12):1311-1321. PubMed ID: 28688824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraindividual Cognitive Variability and Magnetic Resonance Imaging in Aging American Indians: Data from the Strong Heart Study.
    Mascarenhas Fonseca L; Sage Chaytor N; Olufadi Y; Buchwald D; Galvin JE; Schmitter-Edgecombe M; Suchy-Dicey A
    J Alzheimers Dis; 2023; 91(4):1395-1407. PubMed ID: 36641671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain structure and cerebrovascular risk in cognitively impaired patients: Shanghai Community Brain Health Initiative-pilot phase.
    He J; Iosif AM; Lee DY; Martinez O; Chu S; Carmichael O; Mortimer JA; Zhao Q; Ding D; Guo Q; Galasko D; Salmon DP; Dai Q; Wu Y; Petersen RC; Hong Z; Borenstein AR; DeCarli C
    Arch Neurol; 2010 Oct; 67(10):1231-7. PubMed ID: 20937951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study.
    van Maurik IS; Vos SJ; Bos I; Bouwman FH; Teunissen CE; Scheltens P; Barkhof F; Frolich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Frisoni GB; Spiru L; Freund-Levi Y; Wallin AK; Hampel H; Soininen H; Tsolaki M; Verhey F; Kłoszewska I; Mecocci P; Vellas B; Lovestone S; Galluzzi S; Herukka SK; Santana I; Baldeiras I; de Mendonça A; Silva D; Chetelat G; Egret S; Palmqvist S; Hansson O; Visser PJ; Berkhof J; van der Flier WM;
    Lancet Neurol; 2019 Nov; 18(11):1034-1044. PubMed ID: 31526625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral Perfusion and the Risk of Dementia: A Population-Based Study.
    Wolters FJ; Zonneveld HI; Hofman A; van der Lugt A; Koudstaal PJ; Vernooij MW; Ikram MA;
    Circulation; 2017 Aug; 136(8):719-728. PubMed ID: 28588075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological Test Performance and MRI Markers of Dementia Risk: Reducing Education Bias.
    Walter S; Dufouil C; Gross AL; Jones RN; Mungas D; Filshtein TJ; Manly JJ; Arpawong TE; Glymour MM
    Alzheimer Dis Assoc Disord; 2019; 33(3):179-185. PubMed ID: 31206372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid.
    Rosenberg A; Solomon A; Jelic V; Hagman G; Bogdanovic N; Kivipelto M
    Alzheimers Res Ther; 2019 Dec; 11(1):99. PubMed ID: 31805990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.